ClinicalTrials.gg
RecruitingNCT06928740MKI-TDMUpdated Feb 20, 2026

Efficacy on Anxiety of the Digital Music Application Versus Equimolar Mixture of Oxygen and Nitrous Oxide in Patients Receiving CT-guided Lumbar Infiltration

An interventional study of Music Care® device and EMONO in Low Back Pain and Anxiety, sponsored by Centre Hospitalier Universitaire de Nīmes. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-20.

Sponsored by Centre Hospitalier Universitaire de Nīmes · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
128
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Low Back Pain by Centre Hospitalier Universitaire de Nīmes — 3 open to participants now, 3 under way, none of them phase 3. Low Back Pain · Centre Hospitalier Universitaire de Nīmes.

Started
2025
with 1 other
No phase
4 of 12
1 open now
Registered
12th of 12
by date

Among the 12 studies in Low Back Pain by Centre Hospitalier Universitaire de Nīmes, this one is one of 2 that started in 2025, is one of 4 with no phase, and was the 12th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

3 of the 12 studies in Low Back Pain by Centre Hospitalier Universitaire de Nīmes are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Low Back Pain by Centre Hospitalier Universitaire de Nīmes, or all of them as a file.
02

Study summary

Since the Covid-19 crisis, patients appear more stressed, with increasing fear of exams and the hospital environment, in particular for CT scan teams, which require injections. Currently, an equimolar mixture of oxygen and nitrous oxide (EMONO) is used to calm patients. However, the patient's prone position complicates its use, with patients sometimes in painful position and the discomfort of gas inhalation (nausea, dizziness, etc.), as well as reduced lung capacity. Greater patient anxiety increases the risk of complications, or even failure, (unexpected movement, stiffness, refusal to complete the procedure, etc.). In this study, music therapy using Music Care® tablets, was tested to replace EMONO. The study authors hypothesize that the use of the Music Care® device will have a comparable efficacy to that of EMONO (non-inferiority) in reducing patient anxiety during CT-guided lumbar infiltration. Furthermore, the study authors hypothesize that this simple, non-invasive method, with no contraindications for the patient, will be better tolerated and appreciated by both the patient and the paramedical team in charge of the treatment.

03

Conditions studied

  • Low Back Pain
  • Anxiety

Keywords

  • Music therapy
  • Computerized tomography scan
  • ENOMO
  • Radiographer
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The patient must have given their free and and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan
  • Patients with low back pain for whom scan-guided infiltration is indicated, whether at the foraminal level, posterior joints, pudendal, epidural, sacroiliac, or via the sacrococcygeal hiatus.
  • Patient with an anxiety score ≥ 35/100 based on the STAI-ETAT questionnaire

Exclusion criteria

Exclusion Criteria:

  • The subject is participating in another drug or category I interventional study, or is in a period of exclusion determined by a previous study
  • The subject refuses to sign the consent
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • Indication for epidural injection
  • Patient who is deaf or hard of hearing
  • to EMONO
  • Facial or head trauma making it impossible to wear a nasofacial mask or headphones
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
128 participants (estimated)

Study arms

  • Experimental
    Music Care

    Other: Music Care® device

  • Active comparator
    Control

    Other: EMONO

Interventions

  • OtherMusic Care® device

    Installation of the Music Care® device, selection of the sequence based on the patient's musical taste, listening to at least 20-minute sequence in the preparation room. Once placed on the scanner table, the patient listens to the same sequence as in the preparation room.

  • OtherEMONO

    Equimolar mixture of oxygen and nitrous oxide given as usual care

06

What researchers measure

Primary outcomes

  1. Anxiety between groups

    0-100 visual analog scale (VSA)

    Time frame: Baseline

  2. Anxiety between groups

    0-100 visual analog scale (VSA)

    Time frame: Day 0: upon locating helix and a skin location

  3. Anxiety between groups

    0-100 visual analog scale (VSA)

    Time frame: Day 0: before injection of corticosteroids

Secondary outcomes

  1. Patient satisfaction between groups

    0-100 visual analog scale (VSA)

    Time frame: Day 0: Before discharge from imagery department

  2. Patient comfort between groups

    0-100 visual analog scale (VSA)

    Time frame: Day 0: After injection of corticosteroids

  3. Patient-reported pain between groups

    0-100 visual analog scale (VSA)

    Time frame: Day 0: Before injection of corticosteroids

  4. Patient-reported pain between groups

    0-100 visual analog scale (VSA)

    Time frame: Day 0: After injection of corticosteroids

  5. Anxiety between groups according to type of injection (foraminal, pudendal or posterior articular)

    0-100 visual analog scale (VSA)

    Time frame: Day 0: Before injection of corticosteroids

  6. Anxiety between groups according to type of injection (foraminal, pudendal or posterior, articular, epidural, sacroiliac joints, and sacrococcygeal hiatus)

    0-100 visual analog scale (VSA)

    Time frame: Day 0: After injection of corticosteroids

  7. Satisfaction of radiographer between groups

    0-100 visual analog scale (VSA)

    Time frame: Day 0

  8. Rate of adverse events between groups

    According to Common Terminology Criteria for Adverse Events version 5.0 (grade 1-5)

    Time frame: Day 0: During procedure

  9. Rate of adverse events between groups

    According to Common Terminology Criteria for Adverse Events version 5.0 (grade 1-5)

    Time frame: Day 0: immediately after procedure

  10. Rate of complications between groups

    According to Clavien-Dindo (grade I-V)

    Time frame: Day 0: During procedure

  11. Rate of complications between groups

    According to Clavien-Dindo (grade I-V)

    Time frame: Day 0: immediately after procedure

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for Jun 2027, 20 months after the start.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 20 months is above that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 8, 2025
First posted
Apr 15, 2025
StartActual
Oct 21, 2025
Primary completionEst.
Jun 2027
CompletionEst.
Jun 2029
Last update
Feb 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06928740
Responsible party
Sponsor
First posted
Apr 15, 2025
Start date
Oct 21, 2025
Primary completion
Jun 2027 (estimated)
Completion
Jun 2029 (estimated)
Last update
Feb 20, 2026

Study contacts

Florelle TERRA
Contact
florelle.terra@chu-nimes.fr
06.37.59.77.34
Florelle TERRA
principal investigator · Centre Hospitalier Universitaire de Nīmes

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion